ISRCTN97744893进行中（未招募）未知
European Carotid Surgery Trial 2 (ECST-2): a randomised controlled trial
niversity College London (UK)0 个研究点目标入组 429 人开始时间: 2012年7月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 429
研究概览
简要总结
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35897114/ (added 28/07/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients over 18 years of age with atherosclerotic carotid stenosis equivalent to at least 50% measured using the North American Symptomatic Carotid Endarterectomy Trial (NASCET) method
- •2. Patient is medically and neurologically stable and suitable for CEA or carotid artery stenting (CAS)
- •3. Patients with a carotid artery risk (CAR) score indicating a 5-year ipsilateral stroke risk of <20%. This may include patients with asymptomatic stenosis or symptomatic stenosis associated with features (e.g. delayed presentation) indicating intermediate or lower risk, confirmed by CAR Score <20%
- •4. Clinicians are uncertain about which treatment modality is best for the individual patient
- •5. Patient or appropriate representative is able and willing to give informed consent
- •6. Male and female participants
排除标准
- •1. Patients (or their representatives) unwilling to have either treatment modality
- •2. Patients unwilling or unable to participate in follow up for whatever reason
- •3. Patients with a Rankin score greater than 3 for any reason. Such patients may be eligible for inclusion at such time as they improve to a Rankin score of 3 or less
- •4. Patients who are medically or neurologically unstable or have progressing neurological signs. Such patients may be eligible for inclusion at such time as they become stable
- •5. Patients in whom it is planned to carry out coronary artery bypass grafting or other major surgery within one month of carotid stenting or endarterectomy
- •6. Patients with a CAR Score >20% or other reason for believing the patient would get clear benefit from CEA or CAS
- •7. Patients not suitable for either surgery or stenting due to anatomical factors
- •8. Carotid stenosis caused by nonatherosclerotic disease e.g. dissection, fibromuscular disease or neck radiotherapy
- •9. Previous CEA or stenting in the randomised artery
- •10. Patients who are known to be pregnant
- •11. Patients who have a life expectancy of less than two years due to a preexisting condition e.g. cancer
- •12. Patients intolerant or allergic to all of the medications available for optimised modern medical therapy
- •13. Patients in clinical trials of medicinal products (CTIMPS) or who have been in a CTIMP within the last 4 months will not be enrolled
- •14. Patients in other trials (both stroke related and non stroke related) may be enrolled where this would not conflict with the treatments used in ECST2 or place undue additional burdens on the patient
研究者
相似试验
招募中
不适用
The 2nd European Carotid Surgery Trialcarotid narrowingatherosclerotic carotid artery stenosis10007963NL-OMON46858Academisch Medisch Centrum200
已完成
不适用
Asymptomatic Carotid Surgery Trial 2: an international randomised trial to compare carotid endarterectomy with carotid artery stenting to prevent strokeStrokeISRCTN21144362niversity of Oxford (UK)3,625
招募中
4 期
Asymptomatic Carotid Surgery Trial -2 (ACST-2). A randomised trial to compare CEA versus CAS to prevent stroke.carotid plaque10011954carotid artery stenosisNL-OMON47429niversity of Oxford100
已完成
1 期
Acute Carotid Sinus Endovascular Stimulation II StudyHypertensionNCT01458483Medtronic Cardiac Rhythm and Heart Failure9
已完成
不适用
iTEFORM light therapy effectiveness for oral mucositisCancerISRCTN14224600The Newcastle Upon Tyne Hospitals NHS Foundation Trust380